Literature DB >> 7478528

Cloning, characterization, and differential expression of MDK2 and MDK5, two novel receptor tyrosine kinases of the eck/eph family.

T Ciossek1, M M Lerch, A Ullrich.   

Abstract

Using a polymerase chain reaction-based strategy for the cloning of developmentally regulated receptor tyrosine kinases, we identified two novel members of the eck/eph-related subfamily which, in analogy with the recently identified mouse developmental kinase 1 (MDK1), were designated MDK2 and MDK5. MDK2 is highly homologous to the mouse kinase Myk-1 and the human kinase Htk, whereas MDK5 represents the mouse homologue of human Hek2. Northern blot analyses of adult mouse tissues revealed a 4.7 kb transcript of MDK2 and a 4.8 kb transcript of MDK5 in various organ systems, including lung, liver, kidney, intestine, muscle, heart, and, in the case of MDK5, also the brain. In addition to the full-length transcripts, smaller fragments were identified that probably represent truncated receptors. Northern blot analysis and in situ hybridization of mouse embryos indicated abundant expression during embryonic development, with preferential involvement of tissues of epithelial and endothelial origin for both kinases and of the spinal cord gray matter for MDK5. Unlike most other members of the eck/eph-related subfamily, the expression of MDK2 and MDK5 is not primarily restricted to neuronal structures, and their abundant presence in various organ systems during embryonic development suggests an important role in gestational growth and differentiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7478528

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  A role for the Eph ligand ephrin-A3 in entorhino-hippocampal axon targeting.

Authors:  E Stein; N E Savaskan; O Ninnemann; R Nitsch; R Zhou; T Skutella
Journal:  J Neurosci       Date:  1999-10-15       Impact factor: 6.167

2.  EphB6 crosslinking results in costimulation of T cells.

Authors:  Hongyu Luo; Guang Yu; Yulian Wu; Jiangping Wu
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

3.  Loss-of-function analysis of EphA receptors in retinotectal mapping.

Authors:  David A Feldheim; Masaru Nakamoto; Miriam Osterfield; Nicholas W Gale; Thomas M DeChiara; Rajat Rohatgi; George D Yancopoulos; John G Flanagan
Journal:  J Neurosci       Date:  2004-03-10       Impact factor: 6.167

4.  EphB6-null mutation results in compromised T cell function.

Authors:  Hongyu Luo; Guang Yu; Johanne Tremblay; Jiangping Wu
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

Review 5.  Eph/ephrin signaling in the kidney and lower urinary tract.

Authors:  Anna-Carina Weiss; Andreas Kispert
Journal:  Pediatr Nephrol       Date:  2015-04-23       Impact factor: 3.714

6.  The N-terminal globular domain of Eph receptors is sufficient for ligand binding and receptor signaling.

Authors:  J P Labrador; R Brambilla; R Klein
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

7.  Comparative analysis of the gene-dense ACHE/TFR2 region on human chromosome 7q22 with the orthologous region on mouse chromosome 5.

Authors:  M D Wilson; C Riemer; D W Martindale; P Schnupf; A P Boright; T L Cheung; D M Hardy; S Schwartz; S W Scherer; L C Tsui; W Miller; B F Koop
Journal:  Nucleic Acids Res       Date:  2001-03-15       Impact factor: 16.971

8.  Characterization and comparison of four serine- and arginine-rich (SR) protein kinases.

Authors:  O Nayler; S Stamm; A Ullrich
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

9.  Aberrant axonal projections in mice lacking EphA8 (Eek) tyrosine protein kinase receptors.

Authors:  S Park; J Frisén; M Barbacid
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

10.  Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis.

Authors:  R H Adams; G A Wilkinson; C Weiss; F Diella; N W Gale; U Deutsch; W Risau; R Klein
Journal:  Genes Dev       Date:  1999-02-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.